Vertex Pharma stock slips as revenue and EPS stay in view
Published on 09/06/2026 at 17:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Vertex Pharma (ISIN US92532F1003) stock traded at USD 546.12 on September 6, 2026, down 2.12 percent on the day, with market capitalization at USD 138.42 billion. The stock was also shown at USD 546.00 in the same session snapshot, underscoring a tight trading band around the USD 546 area.
Quarterly numbers still matter
According to a MarketBeat earnings snapshot, Vertex reported EPS of USD 4.73 for the quarter on August 3, 2026, which missed the consensus estimate of USD 4.74 by USD 0.01. Revenue came in at USD 3.33 billion, up 12.5 percent from the prior year quarter and above the USD 3.23 billion estimate.
The same source said net margin was 35.00 percent and return on equity was 23.09 percent. That combination keeps the stock expensive on the numbers, with a trailing P/E of 31.79 and a PEG ratio of 2.37.
Chart level near the high
Market data showed a 12-month range of USD 374.17 to USD 560.25, so the September 6 price sits near the upper end of that band. The 50-day moving average stood at USD 509.50 and the 200-day moving average at USD 471.47, both below the latest quote.
Vertex Pharma latest results and market data
The latest quarter showed 12.5 percent revenue growth and a narrow EPS miss, while the share price stayed close to its 12-month high.
VRTX drug portfolio
Vertex still leans on a concentrated product mix in cystic fibrosis, so the market keeps focusing on how well the newer pipeline supports the revenue base. The August 3, 2026 quarter showed USD 3.33 billion in sales, a figure that remains the key reference point for that debate.
Stock still near the upper range
As of September 6, 2026, Vertex Pharma stock was quoted at USD 546.12 on Nasdaq, with a market capitalization of USD 138.42 billion. The 12-month range of USD 374.17 to USD 560.25 leaves the shares close to the top of the band.
Vertex Pharma at a glance
- Company: Vertex Pharmaceuticals Incorporated
- ISIN: US92532F1003
- Ticker: VRTX
- Trading venue: Nasdaq
- Price (as of September 6, 2026): USD 546.12
- Market capitalization: USD 138.42 billion (as of September 6, 2026)
- Sector / Industry: Biotechnology / Pharmaceuticals
